Te Ahumairangi Investment Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.67M | Sell |
5,985
-3,133
| -34% | -$1.4M | 0.48% | 67 |
|
|
2025
Q1 | $4.42M | Sell |
9,118
-3,295
| -27% | -$1.6M | 0.94% | 40 |
|
|
2024
Q4 | $5M | Sell |
12,413
-926
| -7% | -$373K | 1.04% | 32 |
|
|
2024
Q3 | $6.17M | Sell |
13,339
-550
| -4% | -$254K | 1.09% | 33 |
|
|
2024
Q2 | $6.51M | Sell |
13,889
-845
| -6% | -$396K | 1.25% | 28 |
|
|
2024
Q1 | $6.16M | Buy |
14,734
+470
| +3% | +$196K | 1.07% | 35 |
|
|
2023
Q4 | $5.8M | Sell |
14,264
-4,105
| -22% | -$1.67M | 1.1% | 35 |
|
|
2023
Q3 | $6.39M | Sell |
18,369
-3,925
| -18% | -$1.36M | 1.04% | 36 |
|
|
2023
Q2 | $7.85M | Buy |
22,294
+425
| +2% | +$150K | 1.07% | 36 |
|
|
2023
Q1 | $6.89M | Hold |
21,869
| – | – | 0.99% | 38 |
|
|
2022
Q4 | $6.32M | Buy |
21,869
+5,894
| +37% | +$1.7M | 0.99% | 40 |
|
|
2022
Q3 | $4.63M | Buy |
15,975
+35
| +0.2% | +$10.1K | 0.78% | 54 |
|
|
2022
Q2 | $4.49M | Buy |
15,940
+1,160
| +8% | +$327K | 0.68% | 60 |
|
|
2022
Q1 | $3.86M | Buy |
14,780
+1,010
| +7% | +$264K | 0.52% | 69 |
|
|
2021
Q4 | $3.02M | Buy |
+13,770
| New | +$3.02M | 0.39% | 74 |
|